Ferring Pharmaceuticals and Shanghai Dongbao Biopharmaceutical Company announced today the signing of an agreement by which Dongbao Biopharmaceutical will purchase Ferring’s manufacturing operation at Malmö in Sweden…

Speaking today at a Ferring-sponsored symposium on the occasion of the 14th United European Gastroenterology…

Ferring Pharmaceuticals, the pioneering Swiss pharmaceutical group and world leader in industrial synthesis of peptides, today officially opens its new production site and administrative Headquarters in Saint-Prex in the canton of Vaud…

New research conducted by the independent ‘think tank’ RAND Europe discusses one potential solution to the population ageing crisis in Europe that has not yet been considered…

Following the presentation today of the results of the Phase IIb programme with degarelix in prostate cancer, which are in line with previous promising studies, Ferring Pharmaceuticals announced the immediate start of Phase III trials…

Ferring Pharmaceuticals (“Ferring”; headquarters: Lausanne, Switzerland; executive chairman: Frederik Paulsen) and Astellas Pharma Inc….

The world’s leading urology experts have joined forces at a major international meeting to highlight the importance of recognising and treating nocturia, one of the most common causes of sleep disturbance…

Ferring B.V. and Ferring International Centre SA announced today that they have completed the purchase of BTG (Biotechnology General)…

Jens Peter Nørgaard, Ferring’s chief scientific officer for urology in clinical research and development, has been awarded the prestigious Adjunct Professorship of Urology at the University of Lund, Sweden…

Ferring A/S meddelte i dag, at produktionen på virksomheden i Vanløse skal afvikles for helt at ophøre ved udgangen af 2008…